Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Exercise and Diet Sharply Reduce Diabetes Risk

By HospiMedica staff writers
Posted on 15 Aug 2001
A major clinical trial comparing diet and exercise to treatment with metformin or placebo to prevent diabetes was ended a year early because the data demonstrated so clearly that diet and exercise cut the risk of type 2 diabetes by 58%. More...
Called the Diabetes Prevention Program, the trial was funded by the U.S. Institutes of Health (NIH; www.nih.gov) and other organizations. The U.S. prevalence of type 2 diabetes has tripled in the last 30 years, and much of the increase is due to the dramatic upsurge in obesity.

The 3,234 trial participants from 27 medical centers ranged in age from 25-85, with an average age of 51. All had impaired glucose tolerance and all were overweight. The participants were placed in one of three groups: a group taking placebo, a group taking metformin, and a group who exercised 150 minutes a week and lost 5-7% of their body weight by eating a low-fat diet. About 29% of the placebo group developed diabetes during the three-year follow-up, while about 22% of people who took metformin developed the disease. In contrast, only 14% of the people who exercised and lost weight developed diabetes.

"In view of the rapidly rising rates of obesity and diabetes in America, this good news couldn't come at a better time,” said Tommy G. Thompson, secretary of the U.S. Department of Health and Human Services. "So many of our health problems can be avoided through diet, exercise, and making sure we take care of ourselves.”




Related Links:
NIH

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.